Favipiravir exposure and pregnancy outcome of COVID-19 patients
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference26 articles.
1. Efficacy and safety of new and emerging drugs for COVID-19: Favipiravir and dexamethasone;Sood;Curr Pharmacol Rep,2021
2. Role of favipiravir in the treatment of COVID-19;Joshi;Int J Infect Dis,2021
3. Favipiravir: a new medication for the Ebola virus disease pandemic;Nagata;Disaster Med Public Health Prep,2015
4. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses;Delang;Antiviral Res,2018
5. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019;Louchet;Am J Obstet Gynecol,2020
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Convenient screening of the reproductive toxicity of favipiravir and antiviral drugs in Caenorhabditis elegans;Heliyon;2024-08
2. Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure–Property Relationship, and Molecular Docking Study;Molecules;2024-01-16
3. Favipiravir does not appear to be a major teratogen: Case series from Türkiye;Journal of Gynecology Obstetrics and Human Reproduction;2024-01
4. Face‐to‐face: isotretinoin use and pregnancy outcome;International Journal of Dermatology;2023-12-14
5. Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3